Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by...

Area of Science:

• Immunology
• Molecular Biology
• Transplantation Science

Background:

• Histocompatibility matching of human leukocyte antigens (HLA) is crucial for successful transplantation, preventing rejection and graft-versus-host disease.
• Extensive HLA polymorphism limits donor availability and complicates transplant logistics.
• Advances in gene delivery and regulation offer potential for engineering reduced HLA expression in grafts.

Purpose of the Study:

• To investigate if RNA interference (RNAi) can suppress HLA expression in allogeneic cells to evade immune recognition.
• To assess the efficacy of lentivirus-mediated delivery of short hairpin RNA (shRNA) for HLA knockdown.

Main Methods:

• Employed lentivirus-based gene transfer vectors for stable delivery of shRNA constructs targeting HLA.
• Utilized RNA interference (RNAi) to achieve gene silencing of both pan-Class I and allele-specific HLA.
• Quantified surface HLA expression and assessed resistance to T lymphocyte-mediated cytotoxicity in human cells.

Main Results:

• Demonstrated efficient and dose-dependent reduction of surface HLA expression in human cells via lentivirus-mediated shRNA delivery.
• Showcased enhanced resistance of HLA-knockdown cells to alloreactive T lymphocyte-mediated cytotoxicity.
• Confirmed avoidance of MHC-non-restricted killing, indicating specific targeting of HLA.

Conclusions:

• RNAi-induced silencing of HLA expression is a viable strategy to reduce immune recognition of allogeneic cells.
• Lentivirus-mediated shRNA delivery enables stable and efficient HLA knockdown, enhancing graft compatibility.
• This approach holds potential for creating histocompatibility-enhanced, and possibly universally compatible, cellular grafts for transplantation.